TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 2 | 6 | 8 | 15 | 34 | 56 | 20 |
| P | %wins | 75 | 75 | 75 | 75 | 75 | 100 | 79 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/15 19:47 | 12/31/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | P | 6 | 45.23 | 13 | 0 | 0 | 27 | D | 159 | 4 | -17 | 18 | 0 | 0 | -1 | 3 | -2 | 3 | 2 | 41 | 85 | 91 |
7/1/14 12:16 | 6/30/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | P | 14 | 43.79 | 19 | 0 | 1 | 27 | D | 308 | 67 | 15 | -7 | -4 | -10 | -5 | -1 | 2 | -1 | -18 | -24 | -16 | 62 |
1/2/14 16:48 | 12/31/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | P | 7 | 33.92 | 15 | 0 | 1 | 27 | D | 347 | 154 | 36 | 16 | 1 | -2 | -1 | -3 | 1 | 7 | 20 | 28 | 23 | 3 |
7/1/13 15:26 | 6/28/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | P | 14 | 17.36 | 11 | 1 | 6 | 14 | D | 218 | 145 | 74 | 41 | 34 | 17 | 16 | 4 | 7 | 14 | 28 | 14 | 45 | 67 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |